| Control | T2DM | ||
---|---|---|---|---|
Characteristics | ||||
Male | 115 | 124 | ||
Female | 110 | 76 | ||
Total | 225 | 200 | ||
Age | 51.0 ± 11.2 | 68.3 ± 10.3** | ||
Height(cm) | 164.0 ± 8.6 | 161.3 ± 9.0** | ||
Weight (kg) | 62.4 ± 12.6 | 68.8 ± 45.9* | ||
BMI (kg/m2) | 23.1 ± 3.5 | 26.3 ± 17.1** | ||
Systolic BP (mmHg) | 125.0 ± 16.3 | 133.9 ± 19.3** | ||
Diastolic BP (mmHg) | 75.4 ± 11.4 | 73 ± 11.6* | ||
HbA1c(%) | 5.4 ± 0.3 | 7.2 ± 0.8** | ||
FPG (mg/dl) | 91.6 ± 8.5 | 147.9 ± 43.4* | ||
IRI (µU/ml) | 6.8 ± 3.8 | 17.6 ± 32.3** | ||
CPR (ng/ml) | 1.5 ± 0.6 | 2.5 ± 1.6** | ||
T-CHO (mg/dl) | 217.7 ± 41.3 | 190.7 ± 36.2** | ||
TG (mg/dl) | 106.7 ± 86.8 | 138.3 ± 88.2** | ||
HDL (mg/dl) | 68.9 ± 15.6 | 54 ± 14.1** | ||
LDL (mg/dl) | 124.5 ± 32.9 | 107.2 ± 26.8* | ||
Medications | ||||
 | number | (%) | number | (%) |
For hypertension | Â | |||
any | 28 | 12.4 | 104 | 52.0** |
ARB | 16 | 7.1 | 79 | 39.5** |
ACEI | 0 | 0 | 5 | 1.5* |
CaB | 24 | 10.7 | 65 | 32.5** |
α-blocker | 1 | 0.4 | 5 | 2.5 |
β-blocker | 4 | 1.8 | 4 | 2.0 |
diuretics | 1 | 0.4 | 5 | 2.5 |
For dyslipidemia | Â | Â | ||
any | 14 | 6.2 | 79 | 39.5* |
statins | 11 | 4.9 | 73 | 36.5* |
ezetimib | 1 | 0.4 | 5 | 2.5 |
fibrate | 1 | 0.4 | 5 | 2.5 |
vitamin E | 2 | 0.9 | 0 | 0 |
For diabetes | Â | Â | Â | |
any | - | - | 176 | 88 |
DPPIVI | - | - | 116 | 56.9 |
biguanide | - | - | 91 | 45.5 |
SU | - | - | 69 | 34.5 |
αGI | - | - | 30 | 15 |
SGLT2 | - | - | 16 | 8 |
TZD | - | - | 5 | 2.5 |
glinide | - | - | 5 | 2.5 |
insulin | - | - | 46 | 23 |
GLP1 | - | - | 7 | 3.5 |